Triblock Polypeptide Hydrogel with Genipin Cross-Linking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a challenge in applying chemically cross-linked elastin-based polypeptide hydrogels to in vivo injectable systems due to cytotoxicity of reaction byproducts and dynamic reaction processes.
Innovation Solution
A novel triblock polypeptide with phase transition behavior, composed of elastin-based polypeptides and calmodulin, is developed, which forms a dynamic hydrogel suitable for drug delivery and tissue engineering through physical and chemical cross-linking, allowing for multi-stimuli responsiveness and controlled mechanical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If chemically cross-linked elastin-based polypeptide hydrogels are applied to in vivo injectable systems, then mechanical strength and structural stability are improved, but cytotoxicity from reaction byproducts and dynamic reaction processes worsen biocompatibility
Solution Approach 1:
The patent changes the chemical parameters of cross-linking by using genipin instead of traditional glutaraldehyde, which reduces cytotoxicity while maintaining mechanical strength. The genipin cross-linking process operates under milder conditions with fewer toxic byproducts, directly addressing the contradiction between strength and biocompatibility
Solution Approach 2:
The patent employs a biodegradable cross-linking approach where genipin forms reversible cross-links that can be degraded in vivo. This temporary cross-linking provides necessary mechanical strength during implantation but degrades over time to eliminate long-term cytotoxicity, effectively resolving the contradiction between immediate strength requirements and long-term biocompatibility
2Stability of the object's composition
If chemically cross-linked elastin-based polypeptide hydrogels are used, then structural stability is improved, but dynamic reaction processes worsen controllability and predictability
Solution Approach 1:
The patent utilizes self-cross-linking properties of genipin that reacts with amino groups in the polypeptide without requiring additional catalysts or complex reaction conditions. This self-service cross-linking mechanism simplifies the reaction process while producing stable hydrogel structures, resolving the contradiction between stability and process complexity
Solution Approach 2:
The patent replaces complex chemical cross-linking systems with a simpler enzymatic or chemical self-cross-linking mechanism using genipin. This substitution reduces the number of reaction steps and intermediates, making the structural formation process more predictable and controllable while maintaining structural stability
3Adaptability or versatility
If triblock polypeptide structure with calmodulin is designed, then multi-stimuli responsiveness and adaptability are improved, but molecular weight and structural complexity increase
Solution Approach 1:
The patent divides the polypeptide into distinct functional blocks: elastin-based blocks for thermal responsiveness and calmodulin blocks for calcium and ligand responsiveness. This segmentation allows each block to independently respond to specific stimuli while maintaining overall structural organization, resolving the contradiction between multi-stimuli responsiveness and structural complexity
Solution Approach 2:
The patent incorporates calmodulin domains that can bind to multiple types of ligands and respond to various stimuli including calcium ions, temperature changes, and pH variations. This multi-functionality is achieved through the inherent properties of calmodulin rather than adding separate complex components, thus improving adaptability without proportionally increasing structural complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The triblock polypeptide hydrogel exhibits reversible thermally-triggered gelation and ligand responsiveness, forming a stable and biocompatible injectable biomaterial for drug delivery and tissue engineering applications with improved mechanical properties.
Implementation Method 1
a novel polypeptide having a phase transition behavior
Implementation Method 2
formed by physical and chemical crosslinking at the same time
Implementation Method 3
when conformational changes in the biomaterials occur in response to environmental conditions such as temperature, pH, ionic strength and a ligand, protein hydrogels may undergo three dimensional changes
Data Source
AI summary
Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly]n or a [Val-Pro-Ala-Xaa-Gly]n (SEQ ID NO:2) pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.